Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison
ABSTRACT Background Androgen receptor signaling inhibitors (ARSI) combined with androgen deprivation therapy (ADT) have demonstrated significant survival benefits in metastatic hormone‐sensitive prostate cancer (mHSPC) in several clinical trials. However, data specifically in Asian patients remain l...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Wiley
2026-02-01
|
| মালা: | Cancer Reports |
| অনলাইন ব্যবহার করুন: | https://doi.org/10.1002/cnr2.70496 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|